Showing results (31-40 of 79) with videos related to
Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2002
Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexesElke Jäger, Russell Salter, Chiara Castelli, et al.International Journal of Molecular Sciences|July 24, 2021
Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune InterventionMarcella Tazzari, Laura Bergamaschi, Alessandro De Vita, et al.Immunological Reviews|November 26, 2002
Immunity to cancer: attack and escape in T lymphocyte-tumor cell interactionLicia Rivoltini, Matteo Carrabba, Veronica Huber, et al.International Journal of Cancer|January 5, 2002
Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/Mart-1 peptide analogueMarkus J Maeurer, Antje Necker, Russell D Salter, et al.Expert Opinion on Biological Therapy|June 7, 2005
Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?Licia Rivoltini, Paola Canese, Veronica Huber, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2003
Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigenLuisa Novellino, Nicolina Renkvist, Francesca Rini, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
Human plasmacytoid dendritic cells interact with gp96 via CD91 and regulate inflammatory responsesAnnaMaria De Filippo, Robert J Binder, Chiara Camisaschi, et al.Frontiers in Immunology|August 15, 2020
microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer ImmunotherapyElena Daveri, Elisabetta Vergani, Eriomina Shahaj, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|November 15, 2003
Potent phagocytic activity discriminates metastatic and primary human malignant melanomas: a key role of ezrinLuana Lugini, Francesco Lozupone, Paola Matarrese, et al.International Journal of Cancer|March 29, 2002
Peptide-specific CD8+ T-cell evolution in vivo: response to peptide vaccination with Melan-A/MART-1Elke Jäger, Hauni Höhn, Artje Necker, et al.Pageof 8